Evidence map›Paper›PMID 27909742›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2017

The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.

Mahmoud M Said, Maarten C Bosland

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04537780 phase4completednot on this mapstarted 2019, after this paper: background citation

Clinical Study Evaluating the Efficacy and Safety of Montelukast in the Treatment of Non-Alcoholic Steatohepatitis (NASH)

TypeinterventionalSponsorTanta UniversityRan2019 to 2020Enrolled44ConditionsNon Alcoholic SteatohepatitisArmsPlacebo, Montelukast
NCT05959889 nacompletednot on this mapstarted 2023, after this paper: background citation

Evaluating the Effect of Montelukast on Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients.

TypeinterventionalSponsorDamanhour UniversityRan2023 to 2024Enrolled50ConditionsBreast Cancer, Doxorubicin Induced CardiotoxicityArmsAC protocol, Montelukast
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Potential Ameliorative Effect ofArchives of Razi Institute · 2022
    Article
  5. Article
  6. Montelukast potentiates the antiinflammatory effect of NSAIDs in the rat paw formalin model and simultaneously minimizes the risk of gastric damage.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Article
  7. [Establishment of Rat Prostatitis Model through Induction with Estrogen and Androgen at Different Concentrations].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Mahmoud M SaidDepartment of Biochemistry, Faculty of Science, Ain Shams University, Cairo, Egypt. mahmoudmsaid@sci.asu.edu.eg.
Maarten C BoslandDepartment of Pathology, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Ain Shams University · EGUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is no standard treatment of chronic nonbacterial prostatitis in humans. The current study was aimed to investigate the effect of montelukast, an antagonist of cysteinyl leukotriene receptor-1, against estrogen-induced, nonbacterial lateral lobe-specific prostate inflammation in rats. Male Wistar rats were randomized into five groups of six rats, including sham controls (group 1) and castrated rats (group 2), whereas nonbacterial prostatitis (NBP) was induced in groups 3-5 by castration followed by a daily subcutaneous injection of estradiol (0.25 mg/kg body weight) for 30 days. The rats were left otherwise untreated (group 3) or received a daily oral administration of montelukast (1 and 10 mg/kg body weight for groups 4 and 5, respectively) from the 17th day after castration for two consecutive weeks. Compared with sham controls, induction of NBP led to a significant increase in serum leukotriene B

Indexed as

EstradiolAcetatesAnimalsAnti-Inflammatory AgentsChemokine CCL2CyclopropanesDisease Models, AnimalDose-Response Relationship, DrugE-SelectinGene Expression RegulationInflammation MediatorsInterleukin-6Leukotriene AntagonistsLeukotriene B4MaleNF-kappa BAcetatesAnti-Inflammatory AgentsCcl2 protein, ratChemokine CCL2CyclopropanesE-SelectinEstradiolInflammation MediatorsInterleukin-6Leukotriene AntagonistsLeukotriene B4leukotriene D4 receptormontelukastNF-kappa BNitric Oxide Synthase Type IINos2 protein, ratQuinolinesReceptors, LeukotrieneSulfidesTumor Necrosis Factor-alphaChemokinesCytokinesLeukotrienesMontelukastNonbacterial prostatitis

Identifiers

PMID27909742
OpenAlexW2557608482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.